An application of pirfenidone-loaded, lung-targeted nanoliposomes for treating inflammation and early pulmonary fibrosis in ARDS

An application of pirfenidone-loaded, lung-targeted nanoliposomes for treating inflammation and early pulmonary fibrosis in ARDS

Acute respiratory distress syndrome (ARDS) is a common critical respiratory disease with a high mortality rate that has been sustained for many years and is caused by a variety of intrapulmonary and extrapulmonary pathogenic factors. However, the effective clinical interventions for ARDS currently i...

Full description

Bibliographic Details
Main Authors: Sheng Li, Wanshi Chen, Yuhua Zhong, Di Qi, Yiwen Tan, Renzi Zhang, Daoxin Wang
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Materials & Design
Subjects:
ARDS
EndMT
Lung-targeting peptide
Lipid nanoparticles
PFD
Inflammation
Online Access:http://www.sciencedirect.com/science/article/pii/S0264127524001837

Internet

http://www.sciencedirect.com/science/article/pii/S0264127524001837

Similar Items